Research programme: leukotriene A4 hydrolase inhibitors - deCODE genetics

Drug Profile

Research programme: leukotriene A4 hydrolase inhibitors - deCODE genetics

Alternative Names: LTA4H inhibitors - deCODE

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator deCODE genetics
  • Class Ethers; Piperidines; Pyrrolidines
  • Mechanism of Action Leukotriene A4 hydrolase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Myocardial infarction; Stroke

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Stroke in USA
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Myocardial-infarction in USA
  • 17 Apr 2007 Preclinical trials in Stroke in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top